Secukinumab Antibody
Secukinumab is a fully human monoclonal antibody that selectively neutralizes interleukin-17A (IL-17A) . It was the first IL-17A antagonist approved by the FDA for moderate-to-severe plaque psoriasis. This reagent is widely used in immunology and dermatology research, including in vitro cytokine blockade studies and in vivo models of autoimmune inflammation.
Product Specifications
Product Name Alternative
ILReceptor, IL Receptor, IL-17A, Secukinumab
Target
Interleukin, IL Receptor
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
8.2 mg/mL
Purity
97.40% (May vary between batches)
Molecular Weight
147.93 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
DLR-AIRE-Hu-96T 96 Tests
Human Autoimmune Regulator (AIRE) ELISA Kit
Sign In for Pricing
View Details bs-21544R-BF750 100 µL
BRD2 Polyclonal Antibody, AbBy Fluor™ 750 Conjugated
Sign In for Pricing
View Details bs-20205R-BF488 100 µL
Phospho-CDK9 (Thr29) Polyclonal Antibody, AbBy Fluor™ 488 Conjugated
Sign In for Pricing
View Details LV811042 1.0 µg DNA
MUDENG Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details